Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea.
CONCLUSIONS: Compared to sitagliptin therapy, saxagliptin, linagliptin, and gemigliptin therapies were all associated with a lower risk of cardiovascular events.
PMID: 29671284 [PubMed - as supplied by publisher]
Source: Korean Circulation Journal - Category: Cardiology Tags: Korean Circ J Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular | Chronic Kidney Disease | Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Health Insurance | Heart | Heart Attack | Hypertension | Insurance | Januvia | Stroke | Urology & Nephrology